Abstract: The invention relates to a transdermal therapeutic system in the form of a multilayer plaster for the administration of active substances which are able to permeate, in the form of a matrix system containing at least three layers:(a) a covering layer which is impermeable for the constituents of the reservoir b);(b) a reservoir layer which is able to deliver active substance and which consists of optionally crosslinked block copolymer based on styrene, alkadienes and optionally alkenes mixed with adhesive polymers and is optionally provided with an additional adhesive membrane layer and contains at least one active substance capable of skin permeation, at least one agent promoting the skin permeability of active substances and optionally further pharmaceutical auxiliaries, and(c) a protective film which can be pulled off the reservoir layer.

Abstract: An orally administrable formulation of a biologically active, acid sensitive, proteinaceous agent comprises a composition of a lyophilized mixture of the proteinaceous agent and maltose, optionally with a particulate diluent. This composition is then uniformly coated with an alkaline-soluble polymeric film containing at least one partially esterified polymethacrylic acid as a major component.

Abstract: The description is given of a composition, which can be added to the bituminous binder during the preparation of the bituminous conglomerate used for paving roads, for giving the conglomerate high mechanical characteristics and resistance to high and low temperatures.

Abstract: An aqueous hair setting composition having reduced tendency of flaking from the hair containing an alginate hair setting resin and a polymer having in a monomer unit at least one carboxylic acid moiety, said compositions preferably being in the form of an aerosol composition that produces a stable mousse upon delivery from the aerosol container.

Abstract: The present invention relates to topical compositions containing caffeine carboxylates with organic bases, which are useful as slenderizing agents and in the treatment of cellulitis, as well as their preparation.The heterogeneous topical compositions of the invention contain, as active principle, a caffeine carboxylic acid which has been salified with a cosmetologically-acceptable organic base, the active principle preferably being present in the form of microparticles or microgranules suspended in a hydroalcoholic gel.

Abstract: An oil-free and talc-free cosmetic powder composition which is useful as a foundation, blush, lipstick, eye shadow or mascara powder and which comprisesa) about 0.00 to 90.00% of one or more coloring agents,b) about 1.00 to 90.00% of silica,c) about 1.00 to 90.00% of nylon,d) about 1.00 to 90.00% of polymethylmethacrylate ande) about 1.00 to 90.00 of mica,and wherein each of such a) to e) components is in the form of spherical beads having an average particle size in the range of about 1 to 20 microns.

Abstract: A pharmaceutical compositions is provided which has excellent stability, when dispersed in water has a pH of at least about 9, and includes a medicament which is sensitive to a low pH environment such as pravastatin, one or more fillers such as lactose and/or microcrystalline cellulose, one or more binders, such as mirocrystalline cellulose (dry binder) or polyvinylpyrrolidone (wet binder), one or more disintegrating agents such as croscarmellose sodium, one or more lubricants such as magnesium stearate and one or more basifying agents such as magnesium oxide.

Abstract: A coating material for controlling drug release, useful for long acting formulations--e.g. for once-a-day administration, and to a long acting granular composition comprising a drug (especially one conventionally difficult to prepare in long acting form) coated with the coating material. This composition may be mixed with other granular drug formulations. The drug-release controlling coating material comprising, in a specific ration, one specific water-insoluble and low water-permeability polymers and two materials differing from each other in the pH-dependency of their solubility (pH-dependent polymer-materials).

Abstract: Described is an article for the controlled release and delivery to animal tissue of a pharmacologically active agent with or without an excipient and/or enhances which may be a causative factor in the occurrence of non-allergic or allergic contact dermatitis comprising an anti-dermatitis substance.

Abstract: The invention relates to a pharmaceutical composition in the form of a gelatin capsules consisting of a filling containing as active ingredient ranitidine or a physiologically acceptable salt thereof surrounded by a gelatin shell. The filling is formulated based on a non-aqueous matrix consisting of at least one fatty acid glyceride and/or mineral oil or paraffin. Preferably the matrix contains at least one surfactant. The matrix is essentially hydrophobic in character but is also sufficiently hydrophilic to permit dispersion and dissolution of the capsule filling in the gastrointenstinal tract.

Abstract: A sustained-release pharmaceutical preparation comprising an admixture of uncoated and/or single walled coated drug, and multi-units of microparticles of a multi-walled coated drug. The microparticle structure preferably has a core drug, an inner wall microencapsular enteric coating, such as a polymethyacrylic acid/acrylic acid copolymer or cellulose acetate phthalate, a solid acid such as citric acid, adipic acid, or an acidic ion exchange resin layered onto or included in the enteric layer, and an outer wall microencapsulated control coating, such as a polymethacrylic acid ester copolymer or ethyl cellulose. The multi-walled coated drug has a delayed, gradual, long-term release which takes place in the intestines while the uncoated and/or single walled coated drug has immediate therapeutic properties upon dissolution in the stomach. The enteric coating and control coating may be applied to core drug granules by a coacervation, spray coating or other process.

Abstract: A novel glycoside, 4.sup.G -alpha-D-glucopyranosyl rutin, is formed by a saccharide-transferring enzyme and glucoamylase in a solution which contains rutin together with glucoamylase. The 4.sup.G -alpha-D-glucopyranosyl rutin formed in such a solution is purified with a synthetic macroreticular resin, and crystallization in an organic solvent yields a complex crystal with the organic solvent. 4.sup.G -Alpha-D-glucopyranosyl rutin exhibits the same molecular absorption coefficient as intact rutin, and is readily water-soluble, substantially tasteless and odorless, and readily hydrolyzable in vivo to exhibit physiological activities inherent to rutin. These render 4.sup.G -alpha-D-glucopyranosyl rutin very useful as a highly-safe, natural yellow coloring agent, antioxidant, stabilizer, quality-improving agent, preventive, remedy, uv-absorbent and deterioration-preventing agent in foods, beverages, tobaccos, cigarets, feeds, pet foods, pharmaceuticals, cosmetics and plastics.

Abstract: This invention relates to a method of inhibiting fungal growth by employing an antifungal amount of a compound of formula (I): ##STR1##

Abstract: Novel, linear, film-forming polymers and copolymers can be coated on certain metal surfaces, which polymers or copolymers are derived from one or more classes of ethylenically-unsaturated monomers and include at least one novel monomer having a bidentate chelating moiety. The polymers which contain bidentate chelating groups provide significant and varied chemical modification to a metal surface. When coated on a metal surface the polymers are useful as a protective coating or a priming layer.

Abstract: The present invention provides a powdery cosmetic which is excellent in spreadability and adhesion, free from standing-out of powder after application to the skin, free from a dry and loose sensation and has characteristics necessary for powdery cosmetic.The powdery cosmetic of the present invention comprises a porous spherical cellulose powder incorporated therein in an amount of 0.1 to 50% by weight based on the whole amount of the powdery cosmetic. The porous spherical cellulose powder has an average particle diameter of at least 3 .mu.m and coated, impregnated, or chemically linked with at least one high molecular substance retentive of moisture.

Abstract: A termites trail-marking pheromone which is (3Z,6Z,8E)-dodecatrienol, and a composition which comprises (3Z,6Z,8E)-dodecatrienol as an essential component and another component which is a trail-marking pheromone-like substance, and a method of detecting termites by using this composition or (3Z,6Z,8E)-dodecatrienol.The trail-marking pheromone and composition are highly safe in that they have no residual toxicity, and they have a stable, long-term trail-marking effect for termites. This invention provides a simple and rapid method of detecting termites, and a simple and effective method of capturing termites.

Abstract: A carpet and carpet tile resistant to the growth of Gram negative, Gram positive and fungal organisms which contains a polymeric non-plasticized PVC tuftlock precoat, fusion bonding adhesive, or secondary backing which has incorporated in it a phosphoric acid ester or its salt of the general formula: ##STR1## wherein R and R' are alkyl, oxyalkyl, polyoxyalkyl, aryl, aralkyl or alkaryl groups of C.sub.1 to C.sub.24, and one of R or R' can be H; X is a Group I metal ion, Group II metal ion, transition metal ion, or NY.sub.1 Y.sub.2 Y.sub.3 Y.sub.4, where Y.sub.1-4 are hydrogen, a hydrocarbon of C.sub.1 to C.sub.24, or a hydroxyalkyl group of C.sub.1 to C.sub.24 ; and there is at least one free hydroxyl group; and when X is NY.sub.1 Y.sub.2 Y.sub.3 Y.sub.4 or a Group I metal ion, n is 1, when X is a Group II metal ion, n is 2; and when X is a transition metal, n is equal to the valence of the metal.

Abstract: Controlled release microspheres of hydroxybutyrate polymer comprise active ingredient and hydroxybutyrate/hydrovalerate copolymer. The microspheres comprise a skin which is distinct from the general bulk of the microspheres, and this skin may have a porosity covering from 0-50% of the total surface area of the microsphere, this porosity being largely controlled by varying the hydroxyvalerate content of the polymer. The porosity of the interior of the microspheres can also be regulated. Control of the two porosities permits the attainment of a wide range of release rates for a wide range of active ingredients. The microspheres can be used in a wide variety of pharmaceutical, veterinary and agricultural applications.

Abstract: Disclosed is a porous protein particle for delivering over a period of time an active ingredient impregnated therein, and methods of making and using the same. The protein particles have a median size less than about 50 microns. Active ingredient entrapped in the porous structure is gradually released from the protein particle.

Abstract: Transdermal flux enhancers such as oleic acid and 1-dodecylazacycloheptan-2-one are used in combination with iontophoresis in the topical administration of pharmaceutical agents.